Senior Vice President and General Manager, Human Health and Nutrition · BALCHEM CORP (BCPC)

James Hyde

FY2018 is the first fiscal year CompBrief holds for James Hyde as a named executive officer of BALCHEM; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$863,908

Salary $412,167Stock awards $208,634

3rd of 7 named executive officers at Balchem by FY2018 total.

7 named officers on file for BALCHEM, FY2018

James Hyde’s pay file — $29

  • 1 fiscal year of pay, line by line
  • BCPC’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BALCHEM’s whole pay program stands against its peers

  • BALCHEM’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BCPC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2021 (DEF 14A).

Free

Get James Hyde’s full pay file as a PDF — free

More than this page: up to 10 years of James’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

James Hyde compensation by year

BALCHEM Summary Compensation Table · the one fiscal year held
In US dollars, as BALCHEM reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$412,167
Bonus$0
Stock awards$208,634
Option awards$70,756
Non-equity incentive$144,307
Pension and deferred compensation$-3,206
All other$31,250
Total$863,908

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BALCHEM CORP DEF 14A filed April 26, 2021, accession 0001140361-21-014326, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BALCHEM CORP filed document, accession 0001140361-21-014326. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU6,750$777,735—
RSU5,350$616,427—
Option1,520—$74.57
Option4,700—$111.94
Option3,200—$84.09

Per the Outstanding Equity Awards at Fiscal Year-End table in BALCHEM CORP's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

BALCHEM’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Theodore HarrisChairman, President & CEO$3,334,545
Scott MasonVice President of Manufacturing and Supply Chain$962,603
James Hyde · this pageSenior Vice President and General Manager, Human Health and Nutrition$863,908
William BackusChief Accounting Officer$734,331
David LudwigVice President and General Manager, Specialty and Industrial Products$718,228
Mark StachGeneral Counsel$629,943
Mary CoelhoFormer Chief Financial Officer & Treasurer$491,891

The full BALCHEM compensation record

free company brief

This page is one person within BALCHEM's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BALCHEM proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BALCHEM's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

James Hyde's compensation dossier · One-time report. No refunds.